Pharmaceutical Industry Research Report, Pharma Market

sale

Malabsorption Syndrome Market

U

2025

Malabsorption Syndrome Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Malabsorption syndrome is a condition that prevents absorption of nutrients such as carbohydrates, fats, proteins, and vitamins through small intestine. It might be caused due to some damage in the small intestine from infection, medication, surgery, or disorders of some sorts.

Report Code : A14378 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Sjogren’s Syndrome Market

U

2025

Sjogren’s Syndrome Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Sjogren’s syndrome is a progressive autoimmune disease, which is caused by chronic inflammation and the lymphocytic infiltration of exocrine glands.

Report Code : A14381 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Chaple Syndrome Market

U

2025

Chaple Syndrome Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Chaple syndrome is also known as DAF or CD55 deficiency, which refers to a genetic disorder that is rare in nature related to the immune system. CHAPLE is ...

Report Code : A14417 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Aicardi Syndrome Market

U

2025

Aicardi Syndrome Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Aicardi syndrome is a rare genetic disorder, the onset of which begins with involuntary muscle spasm between 4 months to 4 years of age, which, if recurrent, can be fatal at times.

Report Code : A14424 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Blau Syndrome Market

U

2025

Blau Syndrome Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Blau syndrome is a monogenic disease that affects skin, eyes, and the joints. A single modification in one gene present in the body’s cell primarily causes this inflammatory disorder where the symptoms start in childhood, usually before the child is 4 years of age.

Report Code : A14425 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Menkes Syndrome Market

U

2025

Menkes Syndrome Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Menkes syndrome is essentially a rare, X-linked genetic disorder of copper metabolism, which is caused by gene mutations of copper transporter ATP7A that disrupts the copper levels in the body and makes it hard for the body to properly distribute the copper throughout the body.

Report Code : A14445 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Jarcho Levin Syndrome Market

U

2025

Jarcho Levin Syndrome Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Jarcho Levin Syndrome or Spondylocostal Dysostosis is a rare heritable axial skeleton growth disorder and is hence, a condition present by birth. It causes the malformation of vertebral bones, ribs.

Report Code : A14902 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Duane Syndrome Treatment Market

U

2025

Duane Syndrome Treatment Market: Global Opportunity Analysis and Industry Forecast, 2023-2032

Duane syndrome, also known as Duane retraction syndrome (DRS), is a non-progressive congenital strabismus caused by faulty development of the 6th cranial nerve.

Report Code : A15371 | Category : Life Sciences

Price:

~~$3,690~~ $2,583 (30% Off)

License: Cloud Access

PDF, PPT, XLS

sale

Cri-du-chat Syndrome Treatment Market

P

2022

Cri-du-chat Syndrome Treatment Market: Global Opportunity Analysis and Industry Forecast, 2021 - 2031

The global cri-du-chat syndrome treatment market was valued at $1.3 million in 2021, and is projected to reach $1.9 million by 2031, growing at a CAGR of 3.7% from 2022 to 2031.

Report Code : A15445 | Pages : 148 | Category : Life Sciences

Price:

~~$3,570~~ $2,499 (30% Off)

License: Cloud Access

PDF, PPT, XLS

UPDATE AVAILABLE ON DEMAND

Pharmaceuticals

Filter by Region

Filter by Discounts

Filter by Category

Malabsorption syndrome is a condition that prevents absorption of nutrients such as carbohydrates, fats, proteins, and vitamins through small intestine. It might be caused due to some damage in the small intestine from infection, medication, surgery, or disorders of some sorts.

Sjogren’s syndrome is a progressive autoimmune disease, which is caused by chronic inflammation and the lymphocytic infiltration of exocrine glands.

Chaple syndrome is also known as DAF or CD55 deficiency, which refers to a genetic disorder that is rare in nature related to the immune system. CHAPLE is ...

Aicardi syndrome is a rare genetic disorder, the onset of which begins with involuntary muscle spasm between 4 months to 4 years of age, which, if recurrent, can be fatal at times.

Blau syndrome is a monogenic disease that affects skin, eyes, and the joints. A single modification in one gene present in the body’s cell primarily causes this inflammatory disorder where the symptoms start in childhood, usually before the child is 4 years of age.

Menkes syndrome is essentially a rare, X-linked genetic disorder of copper metabolism, which is caused by gene mutations of copper transporter ATP7A that disrupts the copper levels in the body and makes it hard for the body to properly distribute the copper throughout the body.

Jarcho Levin Syndrome or Spondylocostal Dysostosis is a rare heritable axial skeleton growth disorder and is hence, a condition present by birth. It causes the malformation of vertebral bones, ribs.

Duane syndrome, also known as Duane retraction syndrome (DRS), is a non-progressive congenital strabismus caused by faulty development of the 6th cranial nerve.

The global cri-du-chat syndrome treatment market was valued at $1.3 million in 2021, and is projected to reach $1.9 million by 2031, growing at a CAGR of 3.7% from 2022 to 2031.